Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term InvestmentsNon-Current AssetsNon-Current DebtNon-Current Deferred Tax LiabilityNon-Current Deffered RevenueNotes PayablesOperating LeasesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesReceivables - NetRetained EarningsShareholder's EquityShort term DebtTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current Liabilities
Cash Flow Statement
Growth Metrics
Income Statement
Others
Ratios

Celularity (CELUW) Notes Payables (2021 - 2025)

Historic Notes Payables for Celularity (CELUW) over the last 5 years, with Q3 2025 value amounting to $4.3 million.

  • Celularity's Notes Payables changed N/A to $4.3 million in Q3 2025 from the same period last year, while for Sep 2025 it was $4.3 million, marking a year-over-year change of. This contributed to the annual value of $3.9 million for FY2024, which is 7749.52% down from last year.
  • As of Q3 2025, Celularity's Notes Payables stood at $4.3 million.
  • In the past 5 years, Celularity's Notes Payables registered a high of $39.3 million during Q3 2022, and its lowest value of $120000.0 during Q1 2021.
  • Moreover, its 5-year median value for Notes Payables was $9.2 million (2023), whereas its average is $14.5 million.
  • Per our database at Business Quant, Celularity's Notes Payables crashed by 5419.78% in 2023 and then plummeted by 7749.52% in 2024.
  • Celularity's Notes Payables (Quarter) stood at $1.1 million in 2021, then surged by 3289.89% to $37.6 million in 2022, then plummeted by 54.2% to $17.2 million in 2023, then tumbled by 77.5% to $3.9 million in 2024, then rose by 10.53% to $4.3 million in 2025.
  • Its last three reported values are $4.3 million in Q3 2025, $4.3 million for Q2 2025, and $4.2 million during Q1 2025.